MedTrace Logo

Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer

NCT01322893 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-05-22

No results posted yet for this study

Summary

Women with metastatic breast cancer, receiving first line treatment of any kind (chemotherapy, endocrine treatment or treatment with antibodies) will be included in this trial. In connection to treatment, blood samples for determination and enumeration of circulating tumour cells will be collected at different time points. Serum and plasma will be collected and stored for future analysis of RNA and DNA.

Conditions

Sponsors & Collaborators

  • Lund University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01322893 on ClinicalTrials.gov